Mark Warner was featured on the CBC Weekend Business Panel talking about Air Canada & Delta Airlines employee COVID19 vaccine mandates, Shopify‘s new TikTok partnership and the Nirvana baby suing for a sixteenth minute of fame. (August 28, 2021) Mark is a Canadian and U.S. lawyer who has practiced in Toronto, Washington, DC and New York and previously worked on trade and competition issues as counsel in the OECD Trade Directorate, and represented the OECD Trade Directorate at meetings of the WTO Working Group on Trade and Competition and the Working Group on Trade and Investment.
Mark chaired an Insight Research Canadian Sharing Economy Symposium in Toronto in 2015. As a former Acting Legal Director for the Ontario Ministry of Consumer Services, Mark was responsible for prosecutions under the provincial consumer protection laws and regulations. Mark’s experience with online technologies and e-commerce includes: participating in OECD-wide policy work on laws and regulations affecting e-commerce, acting as Chair, ICC Competition Commission Working Party on E-Commerce and Competition Policy, serving as an original ICANN domain name dispute resolution arbitrator for eResolution and WIPO and as Rapporteur of the Hague Conference on Private International Law Commission on Jurisdiction for Torts in Electronic Commerce.
As Legal Director for the Ontario Ministry of Research & Innovation, Mr. Warner was responsible for establishing the Ontario Capital Growth Corporation (OCGC) and providing corporate governance legal advice and secretarial support to its Board of Directors. Mr. Warner’s work with the airline industry includes: successfully coordinating multijurisdictional merger filings and abuse of dominance complaints .
As Legal Director of the Ontario Ministry of Economic Development & Trade, Mr. Warner advised Ontario on the negotiations of the Canada-EU Trade Agreement (CETA) including on IP, patent litigation and drug reimbursement issues and on economic development, research and innovation grants and loans to corporations, including leading global pharmaceutical companies for research, manufacture and clinical trial projects. In private practice, Mr. Warner assisted pharmaceutical clients in the global distribution of HIV / AIDS anti-retroviral drugs and the development of innovative patient access programs in the developing world.
